Silver Based Woundcare Dressing

An estimated 25-40% of patients admitted to hospitals are those with wounds. Amongst these 7-10% contract an infection during hospitalization. While advanced wound dressings and improved procedures present better medical outcomes, the management of chronic/advanced wounds continues to be a complex area of treatment.
Surgical wounds, venous leg ulcers, diabetic foot ulcers, burns and accidents for some of the most difficult wounds to treat, with high amounts of exudate and are frequently risk of infections.

While these add significant financial burden to the individual and the community, the human cost of wounds is often immeasurable – pain, distress, embarrassment, anxiety, prolonged hospital stays, chronic morbidity or even death. An advanced pressure ulcer (stage IV) not only causes the patient considerable pain, but can add three months or longer to the hospital stay. Similar impact is cause by other advanced wounds.

However, a large number of these wounds are preventable/treatable through modern wound dressings that include antibiotic and antibacterial use, debridement, irrigation, vacuum-assisted closure, warming, oxygenation, moist wound healing, and adding cells or other materials to secrete or enhance levels of healing factors.

Amongst these methods, the use of silver as an antibacterial agent is well known and accepted over the years. Antimicrobial Silver can be found in various foam dressings from leading manufacturers and start-ups across the globe. A one of its kind product RTD, goes a step beyond – incorporating Silver, Methylene Blue and Gentian Violet –covalently bonded to a foam matrix.
How RTD Works
RTD is based on a proprietary highly absorbent foam that can absorb 20x its weight in exudate. This allows for a longer wear time between changes and further reduces healing time as well. This highly versatile foam can be used for multiple wound types – diabetic foot ulcers, venous stasis ulcers arterial/ischemic ulcers, post-surgical wounds and burns among others.

It is highly effective against the most commonly acquired infections. Independent lab studies have shown RTD to provide sustained antimicrobial protection including MRSA.

Singlet Oxygen

No known antimicrobial resistance to singlet oxygen

Singlet oxygen (released by the methylene blue) causes damage to cell membranes (lipid), pili (proteins), extracellular DNA, and other biological molecules, all of which play important roles in biofilm formation.

AIM is now available for commercially available for more information & enquiries – email us at

Nuclear Cardiology Software for Image Processing & Quantification

Artificial Intelligence in Medicine

The Artificial Intelligence in Medicine (AIM) program is a Nuclear Cardiology Software for processing and archiving that has established itself as the gold standard among users. AIM a research program of the Department of Medicine at Cedars-Sinai Medical Center – one of the largest non-profit hospitals with thousands of healthcare professionals including 2100+ physicians, 2800+ nurses and researchers


Quantitative Gated SPECT

Over the years, AIM has become the most validated nuclear cardiology software package for imaging. It is also USFDA approved & CE marked in Europe. AIM adds a layer of analysis via features & modules that are unique – providing analysis and processing of 3D images of the heart.

How AIM works

How AIM Works

AIM can operate independent of human intervention, is easy to use and accessible, and has resulted in in improved outcomes, particularly for high risk people without symptoms, such as those with diabetes.

Changing lifestyles, increasing longevity and other risk factors such as hypertension, diabetes, hyperlipidaemia or already established disease) mean CVD causes more deaths than any other cause – becoming the leading cause of fatalities across the world – responsible for over 17million deaths annually. With an increasing patient base, AIM is finding increased use/application growing applications across the ever increasing number of nuclear medicine centers across the globe.

AIM Applications

Global populations are in need of early detection mechanisms, personalized management using counselling and medicines and advanced analysis. While traditional methods have been relied upon for years, the interpretation of the results in a more meaningful manner can now be achieved through software like AIM through:

  • Highly accurate interpretation of cardiac health
  • Timely intervention through rapid results
  • Little to no intervention from cardiologists during analysis
  • Patient records & management

AIM is now available for commercially available for more information & enquiries – click here


Copyright © 2012 SkyQuest Technology Group: Building Invention Economy